HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics packaging

This article was originally published in The Rose Sheet

Executive Summary

FDA restates its 1993 position on use of recycled material in cosmetics packaging in an Aug. 16 letter to CTFA. Although packaging for cosmetics is not subject to approval from the agency, manufacturers are responsible for insuring product safety, Office of Cosmetics & Colors Director John Bailey, PhD, says. Any recycled material legislation should thus take into consideration "the impact on commodities regulated by the FDA, the complexities of post-consumer-use recycling and the technology necessary to produce safe and suitable packaging," he adds. CTFA is expected to use FDA's letter in its lobbing efforts against California packaging bill SB 1110. The bill is in the state Assembly's Committee on Consumer Protection and is not expected to pass before the session ends Sept. 10, but will be taken up next year

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel